MANtJFACTURERS O F ETHICAI, PHARRACEUTICAL PROD UCTS Registered Office: 4th Floor, Sambava Chanbers, Sir. P. M. Road, Fort, Munbai, Mcharashtra, PIN: 400001. Telephone 00 91 (22) 2266 3150 EE[=±TETii:HE]EE Fan 00 91 (22) 2202 4657 Email: [email protected] Wchsite: www.triochemi]roducts.com Corporate Identity Number: L24249MH1972PLC015544

Ref No: TPL PP 2021932 2021; 13th Noveinber 2021

To BSE Limited Corporate Relationship Department, Phiroze ]eejeebhoy Towers, Dalal Street, Foft` Mumbal: 400 001. Security Code No. 512101 -ISIN No.: INE331E01013.

near Sir / Madam,

Sub: Submission of Unaudited Financial Results for the Ouarter and Half Year ended 30th SeDtember 2021

We refer to our letter dated 28th October 2021 on the captioned subject.

Pursuant to Regulation sO and 33 of SEBI qisting Obligations and Disclosure Requironents) Regulations, 2015, In this subject, we wish to inform you that the Board Of Director of the Company at its meeting held today i.e. Saturday, 13h November, 2021 have interalia considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2021 duly revieved by the Audit Committee along with Statement of Assets and hiabilities as at September 30, 2021 and Cash Flow Statement for the half year ended September 30, 2021.

The said financial results, duly signed by the Director & CEO of the company along with the statutory auditor's report are enclosed for your pemsal and records.

Also, infomed that the audited financial results in prescribed fomat will be pul]lished in "Free Presss Tournal" and "Navshakti" newspaper, as required. Please take the sane in you record.

Thankingyou,

your faithfully,

For TRIOCHEM PRODUCTS LIMI'mD

RAM S. DEORA DIRECTOR & CEO DIN: 00312369 Encl.: as above

Pun® Address : 123, Sohrab Hall. 21 Sassoon Road, Opp Jchangir liospital. Puce -411001 . T : 020 4ae 7177 E : [email protected] . W : \^rmi.kdg.coin

Independent Auditors Review Report on Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

TO'

The Board of Directors of TRIOCHEM PRODUCTS LIMITED ("Company")

1. We have reviewed the accompanying statement of unaudited financial results of TRIOCHEM PRODUCTS LIIVIITED ("Company") for the quarter and half year ended September 30, 2021 being submitted by the Company pursuant to Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBl from time to time.
1. The statement is the responsibility of the Company's management and has been approved by Board of Directors. Our responsibility is to express a conclusion on the Statement based on our review of the Statement, which has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("lnd As 34"), specified under Section 133 of the Companies Act, 2013, SEBI Circular CIR/CFD/PAC/62/2016 dated 5 July 2016 (hereinafter referred to as 'the SEBI Circular'), and other accounting principles generally accepted in India.
1. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, `Review of Interim Financial Information performed by Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards (lnd AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.

For Kanu Doshi Associates LLP Chartered Accountants Firm Registration No: 104746W/\/V100096 KUNALSUMANTBHA|?ug#'J£%#AindvELRAL VAKHARIA =;£;p2i H.` a u"o Kunal Vakharia Partner Membership No.: 148916 UDIN: 21148916AAAAJC6115

place: Mumbai Date: 13th November 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2202 4657 E-mall: [email protected] Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

TRIOCHEM PRODUCTS LIMITED

Registered Office : Sambava Chamber, 4th Floor, Sir P M Road, Fort, Mumbai - 400 001.

Website: www.triochemproducts.com

CIN: L24249MH1972PLC015544

STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2021

						(Rs in Lakh) Except EPS
Sr.	Particulars	Quarter Ended			Half Year Ended	Year Ended
No.		30-Sep-21	30-Jun-21	30-Sep-20	30-Sep-21	30-Sep-20	31-Mar-21
		(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Unaudited)	(Audited)
$\mathbf{1}$	Income
	(a) Revenue from Operations	326.27		225.86	326.27	225.86	1,393.84
	(b) Other Income	11.00	18.19	4.38	29.19	5.68	13.38
	Total Income From Operations	337.27	18.19	230.24	355.46	231.54	1,407.22
	Expenses
	(a) Cost of Materials Consumed			226.06		644.54	644.87
	(b) Purchase of stock in trade	549.75			549.75		602.73
	(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade	(274.87)		(47.76)	(274.87)	(472.07)	13.41
	(d) Employees Benefit Expenses	12.78	11.50	16.89	24.28	33.78	66.91
	(e) Finance Costs	1.14	0.38	4.97	1.52	7.06	10.90
	(f) Depreciation and Amortisation Expenses	2.99	2.95	3.46	5.94	6.88	13.88
	(g) Other Expenditure	17.82	18.56	33.79	36.38	53.83	112.64
	Total expenses	309.61	33.39	237.41	343.00	274.02	1,465.33
$\overline{\mathbf{3}}$	Profit before exceptional items and tax	27.66	(15.21)	(7.16)	12.46	(42.47)	(58.11)
$\overline{\bf 4}$	Exceptional items
5	Profit/ (Loss) before tax	27.66	(15.21)	(7.16)	12.46	(42.47)	(58.11)
6	Tax Expense
	(a) Current tax		(0.22)	(0.00)	(0.22)	0.02	(0.75)
	(b) Deferred tax	7.30	(4.06)	(1.73)	3.24	(10.56)	(12.66)
	Total tax expenses	7.30	(4.28)	(1.73)	3.02	(10.54)	(13.41)
	Net Profit/ (Loss) for the period	20.36	(10.93)	(5.43)	9.44	(31.93)	(44.70)
8	Other Comprehensive Income (Net of Taxes)
	(A)(i). Items that will be reclassified to profit or loss
	(ii). Income tax relating to items that will be reclassified to profit or loss					٠
	(B)(i). Item that will not be reclassified to profit or loss	(0.36)	1.68	(1.06)	1.32	(0.95)	(2.34)
	(ii). Income tax relating to items that will not be reclassified to profit or loss	0.09	(0.42)	0.27	(0.33)	0.24	0.59
	Total other Comprehensive Income (net of taxes)	(0.27)	1.26	(0.79)	0.99	(0.71)	(1.75)
$\overline{9}$	Total Comprehensive Income for the period	20.09	(9.67)	(6.22)	10.43	(32.64)	(46.45)
10	Paid-up equity share capital (Face Value of ₹ 10/- per share)	24.50	24.50	24.50	24.50	24.50	24.50
11	Other equity as per Balance Sheet of previous accounting year						1,146.69
12	Earnings per equity share (EPS) (of Rs. 10/- each) (not annualised)
	Basic / Diluted EPS (in Rs.)	8.31	(4.46)	(2.22)	3.85	(13.03)	(18.25)

	STATEMENT OF ASSETS AND LIABILITIES AS AT 30TH SEPTEMBER, 2021
	Particulars	As at	As at
		30-Sep-21	31-Mar-21
		(Unaudited)	(Audited)
A	ASSETS
$\mathbf{1}$	Non-Current Assets
	(a) Property, plant and equipment	80.64	86.39
	(b) Capital work - in - progress	3.24	3.24
	(c) Investment property	7.53	7.72
	(d) Financial assets
	(i) Other financial assets	7.32	7.32
	(e) Deferred tax assets (Net)	0.35	3.92
	(f) Other non current tax assets	0.71	0.71
	(g) Other non current assets	0.98	0.87
	Sub Total - Non- Current Assets	100.77	110.17
$\overline{2}$	Current Assets
	(a) Inventories	360.22	85.36
	(b) Financial Assets
	(i) Trade receivable	365.45	139.06
	(ii) Cash and cash equivalents	299.42	819.72
	(iii) Other financial assets	0.15	0.65
	(c) Other tax assets (net)	49.73	33.17
	(d) Other current assets	44.26	22.07
	Sub Total - Current Assets	1,119.23	1,100.03
	TOTAL ASSETS	1,220.00	1,210.20
B	EQUITY AND LIABILITIES
$\mathbf{1}$	Equity
	(a) Equity share capital	24.50	24.50
	(b) Other equity	1,157.12	1,146.69
	Sub Total - Shareholder's fund	1,181.62	1,171.19
	Liabilities
	(a) Non Current Liabilities
	(a) Deferred tax liabilities (Net)
	(b) Current Liabilities
	(a) Financial liabilities
	(i) Borrowing	33.64	32.44
	(ii) Trade payables (b) Other financial liabilities	1.36
	(c) Other current liabilities	0.80	0.93
	(d) Provisions	2.58	5.64
	(e) Current tax liabilities (Net)	٠	۰
	Sub Total - Liabilities	38.38	39.01
	TOTAL EQUITY AND LIABILITIES	1,220.00	1,210.20

Prog umba

הוסי CHEM

Corporate Identity Number: L24249MH1972PLC015544

Notes:
1) The above unaudited financial results of the Company for the quarter and half year ended September 30, 2021 have been reviewed by the Audit
committee of the Board and approved by the Board of Directors at its meeting held on 13.11.2021.
2) The Unaudited financial results have been prepared in accordance with Indian Accounting Standards (Ind AS), the provisions of the Companies Act, 2013
(the Act), as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).
3) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (IND
AS-108) "Segment Reporting" is not applicable.
4) The Company has considered the possible effects that may arise out of the still unfolding COVID-19 pandemic on the carrying amounts of property,
plant & equipment, inventories, trade receivables, etc. For this purpose, the Company has considered internal and external sources of information up to
the date of approval of the Financial Results including credit reports and related information, economic forecasts, market value of certain investments
etc. Based on the current estimates, the Company does not expect any significant impact on such carrying values. The impact of COVID-19 on the
Company's financial statements may differ from that estimated as at the date of approval of Financial Results.
The Indian Parliament has approved the Code on Social Security, 2020 which would impact the contributions by the company towards Provident Fund
and Gratuity. The Ministry of Labour and Employment has released draft rules for the Code on Social Security, 2020 on November 13, 2020, and has
invited suggestions from stakeholders which are under active consideration by the Ministry. The Company will assess the impact and its evaluation once
the subject rules are notified and will give appropriate impact in its financial statements in the period in which, the Code becomes effective and the related rules to determine the financial impact are published.

6) The Corresponding figures of the previous quarter / year have been regrouped, recasted and reclassified to make them comparable wherever necessary.
FOR TRIOCHEM PRODUCTS LIMITED

RAMU S. DEORA

DIRECTOR & CEO Place: Mumbai
DIN: 00312369 Dated: 13th November, 2021

MANUFACTURERS OF ETHICAL PHARMACEUTICAL PRODUCTS

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra,

PIN 400001 Telephone: 00.91 (22) 2266 3150 Fax: 00.91 (22) 2202 4657

E-mall: info@ amphray.com Website: www.triochemproducts.com